>>On the Market
Healthcare Professionals: Please visit the Aggrastat product website.
Medicure is currently developing a transdermal delivery formulation of its lead
AGGRASTAT (tirofiban HCl).
Septembert 10, 2014
Medicure Reports Financial Results For Fiscal 2014 Read more
August 13, 2014
Medicure Provies Updates on Tardoxal and TEND-TD Study Read more
July 11, 2014
Medicure Announces Shares for Debt Settlement Read more
Sign up to receive email updates such as Press Release nofications and other company news.